1E Therapeutics ^{For Profit}

1E Therapeutics is a drug development company that specializes in creating a new class of programmable oligonucleotide therapeutics to treat chronic and life-threatening diseases, genetically-driven diseases, infectious diseases, CNS disorders, age-related disorders, and metabolic diseases. Their patented platform is uniquely designed to create safer and more targeted therapies that autonomously and precisely silence disease-causing RNAs in human or pathogen cells. Contact info: N/A.